Tue, Jan 27, 2015, 5:39 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • terry_vrng terry_vrng Aug 29, 2014 12:58 AM Flag

    From Barrons August 25--INSMED

    From Barrons August 25

    UBS analyst Andrew Peters and team look for other biotech companies that could be in play:

    While we had viewed InterMune as a top take-out candidate in biotech, we also note our Buy rating on Achillion Pharmaceuticals (ACHN) shares also reflects M&A potential. Further, the premium paid on shares and the likely competitive process underscores the relative scarcity of de-risked high quality assets, and we also highlight Puma Biotechnology (PBYI), Incyte (INCY), Insmed (INSM), and Medivation (MDVN) as potential targets among smid-cap names in our coverage universe.

 
INSM
15.91-0.04(-0.25%)Jan 27 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.